Tied Tube Trial in Glaucoma Surgery

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

152 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-18

Study Completion Date

2025-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable outcome. To assess this the investigator will conduct a, randomized prospective, multi-centered study with collaborators at WashU in St. Louis, Duke University, Indiana University and the University of Pittsburgh. Participants will be randomized to have an AGV placement with tube ligation (no-early flow) and without ligation (allowing for early flow). IOP will be measured at day one, week one, and months, one, three six, and twelve. Additionally, clinical data regarding number of glaucoma medications, and complications post-operative complications will also be collected.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ahmed Glaucoma Valve Surgery With Mitomycin-C

NCT02805257

Glaucoma Primary Open Angle Glaucoma Secondary Glaucoma +1 more

COMPLETED PHASE2

Intraluminal Stenting Versus External Ligation of Ahmed Glaucoma Valve

NCT04508881

Glaucoma

COMPLETED NA

Tube Versus Trabeculectomy (TVT) Study

NCT00306852

Glaucoma

COMPLETED NA

Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma

NCT02260219

Neovascular Glaucoma

TERMINATED NA

The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)

NCT02691455

Glaucoma

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to compare the post-operative surgical outcomes and complication rates in patients with different surgical techniques in the Ahmed FP7 glaucoma valve implant (New World Medical, Inc., Rancho Cucamonga, CA). In particular, the investigator wishes to assess whether delaying early aqueous flow by using a vicryl ligature (as done in most non-valved glaucoma drainage device implantation) will reduce the hypertensive phase, reduce early encapsulation, and optimize healing dynamics to allow for improved long term IOP results compared to standard implantation techniques.

Aggressive early aqueous flow may introduce inflammatory mediators that may increase fibrosis during wound healing. Furthermore, mechanical compression of the tissue surrounding the plate may further lead to a denser capsule and limit aqueous diffusion through Tenon's and conjunctiva. For these reasons, the investigator postulate's that the limitation of early aqueous flow through the Ahmed valve will reduce the rates of hypertensive phase, lead to a thinner and less encapsulated bleb, reduce complication rates such as hypotony, and lead to overall improvement in long-term IOP reduction.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma Eye Ahmed Glaucoma Valve Implantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard Implantation

Intervention Type PROCEDURE

Traditional Ahmed plantation without vicryl ligature

Tied off Tube

Intervention Type PROCEDURE

Ahmed implantation with vicryl ligature

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard Implantation

Traditional Ahmed plantation without vicryl ligature

Intervention Type PROCEDURE

Tied off Tube

Ahmed implantation with vicryl ligature

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects with age at screening ≥ 18 years
* Inadequately controlled glaucoma or ocular hypertension
* Ahmed valve implant as the planned surgical procedure
* Patients with primary glaucomas (Primary Open Angle Glaucoma or Primary Angle Closure Glaucoma) or pseudoexfoliation, pigmentary and traumatic glaucoma with or without a previous failed trabeculectomy or other intraocular surgery.
* Primary tubes included
* Investigators to recruit consecutively all eligible patients from their clinics.
* Capable and willing to provide consent

Exclusion Criteria

* Subjects with NLP vision
* Subjects unable/unwilling to provide informed consent
* Unavailable for regular follow up
* Previous cyclodestructive procedure
* Prior scleral buckling procedure or other external impediment to drainage device implantation
* Presence of silicone oil
* Vitreous in the anterior chamber sufficient to require a vitrectomy
* Uveitic glaucoma
* Neovascular glaucoma
* Nanophthalmos
* Patients with pathology that may cause elevated episcleral venous pressure
* Procedure combined with ocular surgery other than cataract surgery (i.e. combined tube-cataract surgery is okay)
* Any abnormality other than glaucoma in the study eye that could affect tonometry.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No